Showing results (11-20 of 615) with videos related to

Sort By:
Pageof 62
Antimicrobial Agents and Chemotherapy|February 1, 1994
A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infectionsA Wald, J Benedetti, G Davis, et al.
The Journal of Clinical Investigation|March 1, 1997
Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatmentA Wald, L Corey, R Cone, et al.
Journal of Clinical Microbiology|May 15, 1999
Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samplesA J Ryncarz, J Goddard, A Wald, et al.
Archives of Family Medicine|March 1, 1995
Seroprevalence of herpes simplex virus infections in a family medicine clinicL Oliver, A Wald, M Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factorsM R Krone, A Wald, S R Tabet, et al.
The Journal of Infectious Diseases|November 7, 1998
Herpes simplex virus shedding among human immunodeficiency virus-negative men who have sex with men: site and frequency of sheddingM R Krone, S R Tabet, M Paradise, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2001
CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cellsD M Koelle, H B Chen, M A Gavin, et al.
The New England Journal of Medicine|March 23, 2000
Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive personsA Wald, J Zeh, S Selke, et al.
Mucosal Immunology|June 12, 2014
Persistence of mucosal T-cell responses to herpes simplex virus type 2 in the female genital tractC M Posavad, L Zhao, D E Mueller, et al.
Journal of Virology|November 9, 2000
CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteinsD M Koelle, M Schomogyi, C McClurkan, et al.
Pageof 62